. 2015 Jul 11;15:515. doi: 10.1186/s12885-015-1523-3

Table 2.

Unadjusted and adjusted OR’s for MDT decision to propose nonstandard treatment

Characteristic		OR unadjusted	95 % CI	OR adjusted ^b	95 % CI
Age	<65 years ^a	1.22	0.7–1.9	1.46	0.9–2.4
Age	≥65 years	1.22	0.7–1.9	1.46	0.9–2.4
Gender	Male ^a	0.72	0.4–1.2	0.72	0.4–1.3
Gender	Female	0.72	0.4–1.2	0.72	0.4–1.3
Comorbidity score (ACE-27)	Low (0–1) ^a	3.06*	1.9–4.8	3.40*	2.0–5.7
Comorbidity score (ACE-27)	High (2–3)	3.06*	1.9–4.8	3.40*	2.0–5.7
Tumor stage	Early (I-II) ^a	5.74*	3.0–11.0	3.40*	1.4–8.5
Tumor stage	Advanced (III-IV)	5.74*	3.0–11.0	3.40*	1.4–8.5
Tumor site	Oral cavity ^a
	Pharynx	2.75*	1.6–4.9	0.94	0.4–2.2
	Larynx	1.69	0.9–3.3	0.85	0.3–2.1
Prior malignancy	No ^a
	Other prior cancer yet treated	0.78	0.3–1.6	0.61	0.3–1.5
	Prior head and neck cancer yet treated	1.60	0.8–3.1	2.56*	1.1–5.7
Marital status	Partner ^a	1.83*	1.2–2.9	1.68	1.0–2.9
Marital status	Single	1.83*	1.2–2.9	1.68	1.0–2.9
Children	Yes ^a
	No	1.23	0.7–2.1	1.07	0.6–2.0
	Unknown	0.79	0.4–1.5	1.31	0.7–2.7
	No contact	0.84	0.7–1.1	0.90	0.7–1.1
Standard treatment according to guidelines	Surgery ^a
	Radiotherapy	1.37	0.5–4.1	1.31	0.4–4.5
	Chemoradiation	8.29*	3.2–21.5	4.79*	1.3–17.1
	Surgery + radiotherapy	2.53	0.9–7.0	1.13	0.3–4.0
	Surgery + chemotherapy	8.00*	1.6–39.0	4.61	0.7–29.5
	Surgery + PORT on indication	0.86	0.2–3.3	0.98	0.2–4.2
Year of treatment	2010 ^a
	2011	0.71	0.4–1.3	0.56	0.3–1.1
	2012	1.04	0.6–1.7	1.11	0.6 2.0

^a = reference value, ^b = odds ratio calculated using multivariate logistic regression analysis adjusting for age, gender, comorbidity, tumor stage, tumor site, prior malignancy, marital status, having children, standard treatment proposal according to guidelines, year of treatment, * = p value < 0.05